6-Bromoimidazo[1,2-a]pyridine-8-carbaldehyde, 98%, 1g

(R)-2-(Methylamino)-3-phenylpropanoic acid, 95.0%, 100g

5-(3-Chlorophenyl)-2-(piperidin-1-yl)-[1,3]thiazolo[4,5-b]pyridine-7-carboxylic acid, 97%, 250mg

2-Fluoro-3-methoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine, 98%, 5g

(R)-Piperidin-3-ol, 97%, 5g

4-Carboxymethyl-piperazine-1-carboxylic acid benzyl ester, 95.0%, 2.5g

Methyl 2-(trifluoromethyl)-1,2,3,4-tetrahydroquinoline-6-carboxylate, 95.0%, 1g

6-Nitro-1,3-benzoxazol-2(3H)-one, 97.0%, 10g

Dibenzo[b,e][1,4]dioxine>99.0%(GC)5g

(2E)-3-(2-ethoxyphenyl)-1-(3-nitrophenyl)prop-2-en-1-one, 95.0%, 10g

[1,1'-Biphenyl]-4-carboximidamide hydrochloride, 95.0%, 1g

2-Methoxyacetimidamide hydrochloride, 95.0%, 5g

Ácido acetoxivalerénico, con analyt. Documentos, 25 mg, envase de vidrio